Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
MORF-057 by Eli Lilly and Co for Ulcerative Colitis: Likelihood of Approval
MORF-057 is under clinical development by Eli Lilly and Co and currently in Phase II for Ulcerative Colitis. According to...
Data Insights
MORF-057 by Eli Lilly and Co for Crohn's Disease (Regional Enteritis): Likelihood of Approval
MORF-057 is under clinical development by Eli Lilly and Co and currently in Phase II for Crohn's Disease (Regional Enteritis)....